Indaptus Therapeutics
Quarterly Financials
| Values in thousands | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|
Revenue | $0 | $0 | $1 |
Gross Profit | 1 | ||
EBITDA | -4,108 | -3,942 | -4,179 |
EBIT | -3,943 | -4,179 | |
Net Income | -4,015 | -3,806 | -4,002 |
Net Change In Cash | 0 | 0 | 1 |
Free Cash Flow | -2,477 | -3,936 | -2,601 |
Cash | 7,301 | 9,741 | 13,362 |
Basic Shares | 8,543 | 8,442 | 8,401 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -1 | -1 | -1 | |
EBITDA | -16,377 | -14,909 | -7,727 | -3,598 |
EBIT | -16,378 | -14,910 | -7,729 | -3,599 |
Net Income | -15,423 | -13,734 | -7,693 | -3,569 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -13,405 | -13,250 | -11,294 | -3,324 |
Cash | 13,362 | 9,626 | 39,132 | 1,637 |
Basic Shares | 8,401 | 8,262 | 4,090 | 486 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$0.32 |
2024-06-30 | -$0.47 |
2024-03-31 | -$0.45 |
2023-12-31 | -$0.48 |
